NASDAQ: ATEX
Anterix Inc Stock

$30.99+3.16 (+11.35%)
Updated Jan 17, 2025
ATEX Price
$30.99
Fair Value Price
-$14.66
Market Cap
$576.98M
52 Week Low
$27.37
52 Week High
$42.41
P/E
-15.34x
P/B
4.15x
P/S
124.84x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.61M
Earnings
-$37.37M
Gross Margin
100%
Operating Margin
-619.1%
Profit Margin
-666.5%
Debt to Equity
1.28
Operating Cash Flow
$35M
Beta
0.87
Next Earnings
Feb 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ATEX Overview

Anterix Inc. operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks, technologies, and solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico. The company was formerly known as pdvWireless, Inc. and changed its name to Anterix Inc. in August 2019. Anterix Inc. was incorporated in 1997 and is headquartered in Woodland Park, New Jersey.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ATEX's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
D
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Telecom

Industry Rating
C
ATEX
Ranked
#29 of 31

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$14.17A
$27.01A
$14.08A
View Top Telecom Stocks

Be the first to know about important ATEX news, forecast changes, insider trades & much more!

ATEX News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ATEX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATEX ($30.99) is overvalued by 311.34% relative to our estimate of its Fair Value price of -$14.66 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ATEX ($30.99) is not significantly undervalued (311.34%) relative to our estimate of its Fair Value price of -$14.66 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ATEX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ATEX due diligence checks available for Premium users.

Valuation

ATEX fair value

Fair Value of ATEX stock based on Discounted Cash Flow (DCF)

Price
$30.99
Fair Value
-$14.66
Undervalued by
311.34%
ATEX ($30.99) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATEX ($30.99) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATEX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATEX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-15.34x
Industry
20.65x
Market
30.45x

ATEX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.15x
Industry
1.7x
ATEX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATEX's financial health

Profit margin

Revenue
$1.6M
Net Income
-$12.8M
Profit Margin
-823.1%
ATEX's Earnings (EBIT) of -$34.71M... subscribe to Premium to read more.
Interest Coverage Financials
ATEX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$317.2M
Liabilities
$178.2M
Debt to equity
1.28
ATEX's short-term assets ($56.77M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATEX's long-term liabilities ($162.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATEX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ATEX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.6M
Investing
-$5.5M
Financing
-$362.0k
ATEX's operating cash flow ($34.77M)... subscribe to Premium to read more.
Debt Coverage Financials

ATEX vs Telecom Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ATEXD$576.98M+11.35%-15.34x4.15x
SHENF$637.75M-0.17%2.97x0.69x
RBBNB$706.80M+0.25%-12.59x1.79x
OOMAA$382.59M+1.14%-38.30x4.58x
WOWC$380.64M-0.66%-4.01x1.76x

Anterix Stock FAQ

What is Anterix's quote symbol?

(NASDAQ: ATEX) Anterix trades on the NASDAQ under the ticker symbol ATEX. Anterix stock quotes can also be displayed as NASDAQ: ATEX.

If you're new to stock investing, here's how to buy Anterix stock.

What is the 52 week high and low for Anterix (NASDAQ: ATEX)?

(NASDAQ: ATEX) Anterix's 52-week high was $42.41, and its 52-week low was $27.37. It is currently -26.93% from its 52-week high and 13.23% from its 52-week low.

How much is Anterix stock worth today?

(NASDAQ: ATEX) Anterix currently has 18,618,271 outstanding shares. With Anterix stock trading at $30.99 per share, the total value of Anterix stock (market capitalization) is $576.98M.

Anterix stock was originally listed at a price of $40.00 in Feb 3, 2015. If you had invested in Anterix stock at $40.00, your return over the last 9 years would have been -22.53%, for an annualized return of -2.8% (not including any dividends or dividend reinvestments).

How much is Anterix's stock price per share?

(NASDAQ: ATEX) Anterix stock price per share is $30.99 today (as of Jan 17, 2025).

What is Anterix's Market Cap?

(NASDAQ: ATEX) Anterix's market cap is $576.98M, as of Jan 18, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Anterix's market cap is calculated by multiplying ATEX's current stock price of $30.99 by ATEX's total outstanding shares of 18,618,271.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.